ReechPharma
ReechPharma is a formulation development company located in the San Francisco Bay Area, specializing in customized formulation solutions to address each drug's unique physicochemical, biopharmaceutical, IP, and regulatory challenges. With over 60+ years of combined experience, they support pharma and biopharma companies through discovery, preclinical, clinical, and life cycle management products, offering a wide range of services including preclinical formulations, clinical formulations, life cycle management, drug-device combination products, and expert consulting. Their mission is to improve clinical success rates through tailored formulations and innovative drug delivery systems.
Industries
Nr. of Employees
small (1-50)
ReechPharma
Products
Preclinical Formulation
Preclinical formulation development services tailored to address drug physicochemical, biopharmaceutical, IP, and regulatory challenges.
Preclinical Formulation Development
Formulation development services supporting pharma and biopharma companies with their discovery and preclinical programs.
Clinical Formulation Services
Clinical formulation development and clinical supply manufacturing services to support drug product development needs at any stage of clinical development.
Customized Formulation Development Services
Customized formulation solutions designed to address each drug's unique physicochemical, biopharmaceutical, IP, and regulatory challenges in alignment with FDA and global regulations.
Solubility Enhancement
Services focused on enhancing the solubility of poorly soluble drug substances to improve bioavailability and efficacy.
Lipid Formulations
Design and optimization of lipid-based drug formulations to enhance drug solubility and delivery.
Preclinical Formulation
Preclinical formulation development services tailored to address drug physicochemical, biopharmaceutical, IP, and regulatory challenges.
Preclinical Formulation Development
Formulation development services supporting pharma and biopharma companies with their discovery and preclinical programs.
Clinical Formulation Services
Clinical formulation development and clinical supply manufacturing services to support drug product development needs at any stage of clinical development.
Customized Formulation Development Services
Customized formulation solutions designed to address each drug's unique physicochemical, biopharmaceutical, IP, and regulatory challenges in alignment with FDA and global regulations.
Solubility Enhancement
Services focused on enhancing the solubility of poorly soluble drug substances to improve bioavailability and efficacy.
Lipid Formulations
Design and optimization of lipid-based drug formulations to enhance drug solubility and delivery.
Services
Formulation and analytical services to support preclinical studies, including preformulation, prototype formulations for DMPK/Tox/Efficacy, solubility/permeability solutions, and GLP formulation supply.
Development and scale-up of clinical dosage forms across immediate, modified and extended release oral forms, liquids, semisolids and novel delivery systems for First-in-Human through late-stage clinical development.
Formulation redesign and development for label expansion and lifecycle claims such as pediatric formulations, modified release/PK modification, new routes of administration, fixed-dose combinations and novel delivery systems.
Pharmaceutical formulation and characterization for drug-device combination products, including compatibility/interaction studies, drug release kinetics and ICH stability testing.
Access to subject-matter experts for candidate selection, biopharmaceutics/PK, analytical development, regulatory submissions, technology transfer, GMP audits, manufacturing scale-up and IP strategy.
Formulation and analytical services to support preclinical studies, including preformulation, prototype formulations for DMPK/Tox/Efficacy, solubility/permeability solutions, and GLP formulation supply.
Development and scale-up of clinical dosage forms across immediate, modified and extended release oral forms, liquids, semisolids and novel delivery systems for First-in-Human through late-stage clinical development.
Formulation redesign and development for label expansion and lifecycle claims such as pediatric formulations, modified release/PK modification, new routes of administration, fixed-dose combinations and novel delivery systems.
Pharmaceutical formulation and characterization for drug-device combination products, including compatibility/interaction studies, drug release kinetics and ICH stability testing.
Access to subject-matter experts for candidate selection, biopharmaceutics/PK, analytical development, regulatory submissions, technology transfer, GMP audits, manufacturing scale-up and IP strategy.
Expertise Areas
- Formulation development (preclinical through clinical)
- API preformulation and characterization
- Solubility and permeability enhancement
- Dosage form development (oral, liquid, semisolid)
Key Technologies
- Hot-melt extrusion
- Nanomilling / particle size reduction
- HPLC / UPLC analytics
- Dissolution testing (multimedia, biorelevant)